Times Square Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Times Square Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$79.4 - $116.36 $5.83 Million - $8.54 Million	73,400 Added 10.62%	764,800 $61 Million
Q1 2022 May 06, 2022	BUY	$86.42 - $109.81 $17.9 Million - $22.8 Million	207,500 Added 42.88%	691,400 $72.7 Million
Q4 2021 Feb 04, 2022	BUY	$98.56 - $119.91 $11.2 Million - $13.6 Million	113,800 Added 30.75%	483,900 $52.1 Million
Q3 2021 Nov 08, 2021	BUY	$91.91 - $110.37 $34 Million - $40.8 Million	370,100 New	370,100 $40.5 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.